Domanegg K

Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.

3 papers · 1 preprint · ORCID

ArticleKetamine

A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse.

Meinhardt MW, Skorodumov I, Jeanblanc J +10

Europe PMC2025
ArticlePsilocybin

Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction.

Habelt B, Afanasenkau D, Schwarz C +7

Europe PMC2024
PreprintPsilocybin

Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction

Habelt B, Afanasenkau D, Schwarz C +7

Europe PMC2024
ArticlePsilocybin

Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.

Domanegg K, Sommer WH, Meinhardt MW

Europe PMC2023